Zobrazeno 1 - 10
of 138
pro vyhledávání: '"N. L. Ascher"'
Publikováno v:
Hepatology. 20:S24-S27
Since the introduction of techniques to reliably identify antibody to the hepatitis C virus and quantitation of hepatitis C virus, there has been an increasing interest in the behavior of chronic hepatitis C infection with liver transplantation. Nine
Publikováno v:
Diabetes. 42:1520-1527
Publikováno v:
Transplantation. 72(5)
Although prolonged composite tissue allograft (CTA) survival is achievable in animals using immunosuppressive drugs, long-term immunosuppression of CTAs in the clinical setting may be unacceptable for most patients. The purpose of this study was to d
Autor:
S M, Kang, D, Braat, D B, Schneider, R W, O'Rourke, Z, Lin, N L, Ascher, D A, Dichek, S, Baekkeskov, P G, Stock
Publikováno v:
Transplantation. 69(9)
Fas ligand (FasL) mediates apoptosis of susceptible Fas-expressing lymphocytes, and may contribute to the maintenance of peripheral tolerance. In transplantation models, however, artificial expression of FasL on cellular as well as islet transplants
Publikováno v:
Transplantation. 69(7)
Dendritic cells are potent antigen-presenting cells that bind allogeneic T cells. They are thus candidates for targeting immunoregulatory molecules to the alloreactive T cell compartment and suppressing the alloimmune response.A dendritic cell line d
Publikováno v:
Transplantation. 69(2)
Daclizumab is a monoclonal antibody directed against the alpha chain of the interleukin 2 receptor. We review our experience with the use of daclizumab in liver transplant recipients.Thirty-two patients were given daclizumab as induction therapy in t
Autor:
G J, Chang, H D, Mahanty, F, Vincenti, C E, Freise, J P, Roberts, N L, Ascher, P G, Stock, R, Hirose
Publikováno v:
Clinical transplantation. 14(6)
Delayed graft function (DGF) after renal transplantation is a significant risk factor for early acute rejection and graft loss. Sirolimus (SRL) can be administered in the setting of DGF without exacerbating the impaired renal function after transplan
Publikováno v:
Transplantation. 67(5)
Mycophenolate mofetil (MMF) has been shown to have promise in short-term liver transplantation graft rescue studies. The purpose of this study was to evaluate the long-term efficacy and safety of MMF in liver transplant patients who had failed cyclos
Publikováno v:
Transplantation. 67(4)
Long-term results after liver transplantation for hepatocellular carcinoma have been disappointing, largely because of the high recurrence rate. It is controversial whether the immunosuppressed state of the recipient contributes to this recurrence ra
Publikováno v:
Clinical transplantation. 12(6)
A 58-yr-old female with primary biliary cirrhosis underwent an uncomplicated orthotopic liver transplantation. Elevated liver function tests 2 months post-transplantation were evaluated with Doppler ultrasound and a hepatic artery stricture was docum